Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
Những tác giả chính: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Springer Nature
2017
|
Những quyển sách tương tự
-
Pentoxifylline in patients with oral submucous fibrosis
Bằng: Ashwini Deshpande, et al.
Được phát hành: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
Bằng: Santosh Patil, et al.
Được phát hành: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
Bằng: Yifan Lin, et al.
Được phát hành: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
Bằng: Arun S, et al.
Được phát hành: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
Bằng: Hiren A. Dhameliya, et al.
Được phát hành: (2020-05-01)